www.fdanews.com/articles/177214-polyganics-secures-ce-mark-for-neurocap
Polyganics Secures CE Mark for NEUROCAP
June 22, 2016
Netherlands-based Polyganics has received CE marking for Neurocap to treat and reduce neuroma formation.
The nerve capping device is an absorbable implant designed to shield a peripheral nerve end to avoid the development of symptomatic end-neuroma.
The company plans on launching the product, which was cleared last January, in some EU countries later this year. — Anisa Jibrell